MENU
HEPA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Hepion Pharmaceuticals (HEPA) Ownership - Who owns Hepion Pharmaceuticals?
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases... Show more
Profile
Industry
N/A
Address
399 Thornall Street
Phone
+1 732 902-4000
Employees
25
Web
https://www.hepionpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
442.8K
P/E Ratio
N/A
Total Cash
1.5M
Projected Growth
N/A
Total Debt
2.22M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
HEPA
Capitalization
443K
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.5M
Total Cash/Share
1.39
Total Debt
2.22M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-2.1M
P/B Ratio
2.11
Cash Flow
N/A
Earnings
-220
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
663
Current Ratio
1.30
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-29.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-158.12
Shares Held By Institutions
N/A
Shares Outstanding - Current
1.08M
Total Liabilities
4.12M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-98.128
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
399 Thornall Street
Phone
+1 732 902-4000
Employees
25
Web
https://www.hepionpharma.com